Ardelyx (ARDX) EBT Margin Growth (1y) (2014 - 2026)
Ardelyx (ARDX) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ardelyx |
1.49 Bn |
1.25 Bn |
89.66 Mn |
1,456.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
1,456.00 |
| Dec 31, 2025 |
-435.00 |
| Sep 30, 2025 |
-2,472.00 |
| Jun 30, 2025 |
285.00 |
| Mar 31, 2025 |
300.00 |
| Dec 31, 2024 |
8,688.00 |
| Sep 30, 2024 |
-1,289.00 |
| Jun 30, 2024 |
5,428.00 |
| Mar 31, 2024 |
17,801.00 |
| Dec 31, 2023 |
-10,706.00 |
| Sep 30, 2023 |
47,126.00 |
| Jun 30, 2023 |
98,953.00 |
| Mar 31, 2023 |
576,228.00 |
| Dec 31, 2022 |
354,549.00 |
| Sep 30, 2022 |
325,663.00 |
| Jun 30, 2022 |
237,532.00 |
| Mar 31, 2022 |
-549,394.00 |
| Dec 31, 2021 |
-192,515.00 |
| Sep 30, 2021 |
-304,832.00 |
| Jun 30, 2021 |
-208,225.00 |
